Showing results (201-210 of 209) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Chemmedchem|August 4, 2020
Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory ActivityTim Van de Walle, Marina Briand, Ana Mitrović, et al.Journal of Medicinal Chemistry|January 10, 2020
Stereoselective Activity of 1-Propargyl-4-styrylpiperidine-like Analogues That Can Discriminate between Monoamine Oxidase Isoforms A and BDamijan Knez, Natalia Colettis, Luca G Iacovino, et al.Acta Neuropathologica|September 24, 2009
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomasCarole Colin, Brigitte Voutsinos-Porche, Isabelle Nanni, et al.Journal of Medicinal Chemistry|December 12, 2017
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo ActivityUrban Košak, Boris Brus, Damijan Knez, et al.European Journal of Medicinal Chemistry|October 16, 2018
A road map for prioritizing warheads for cysteine targeting covalent inhibitorsPéter Ábrányi-Balogh, László Petri, Tímea Imre, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 ReplicationIlona Bereczki, Henrietta Papp, Anett Kuczmog, et al.Scientific Reports|September 26, 2022
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteriaIlona Bereczki, Vladimir Vimberg, Eszter Lőrincz, et al.Acta Pharmaceutica Sinica. B|May 30, 2023
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseasesDamijan Knez, Daniel Diez-Iriepa, Mourad Chioua, et al.Scientific Reports|December 22, 2016
Development of an in-vivo active reversible butyrylcholinesterase inhibitorUrban Košak, Boris Brus, Damijan Knez, et al.Pageof 21